New options for second-line therapy of advanced renal cancer

被引：1
|
作者：
Bex, Axel [1 ]
机构：
[1] Netherlands Canc Inst, Div Surg Oncol Urol, NL-1066 CX Amsterdam, Netherlands
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 06期
关键词：
CELL CARCINOMA; SURVIVAL; TRIAL;
D O I：
10.1016/S1470-2045(13)70119-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：450 / 451
页数：2
相关论文
共 50 条
  • [41] Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer
    Tsang, Erica S.
    Wong, Hui-li
    Wang, Ying
    Renouf, Daniel J.
    Cheung, Winson Y.
    Lim, Howard J.
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (02): : 196 - 201
  • [42] Docetaxel: Efficacy in first- and second-line therapy of advanced breast cancer
    Crown, J
    [J]. ONKOLOGIE, 2000, 23 : 1 - 3
  • [43] First- and second-line therapy for advanced nonsmall cell lung cancer
    Sculier, J-P.
    Moro-Sibilot, D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (04) : 915 - 930
  • [44] Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1178 - 1179
  • [45] Advanced gastric cancer: Is there enough evidence to call second-line therapy standard?
    Arkenau, Hendrik-Tobias
    Saggese, Matilde
    Lemech, Charlotte
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (44) : 6376 - 6378
  • [46] Second-line therapy in elderly patients with advanced nonsmall cell lung cancer
    Quoix, Elisabeth
    Westeel, Virginie
    Moreau, Lionel
    Pichon, Eric
    Lavole, Armelle
    Dauba, Jerome
    Debieuvre, Didier
    Souquet, Pierre Jean
    Bigay-Game, Laurence
    Dansin, Eric
    Poudenx, Michel
    Molinier, Olivier
    Vaylet, Fabien
    Moro-Sibilot, Denis
    Herman, Denis
    Sennelart, Helene
    Tredaniel, Jean
    Mennecier, Bertrand
    Morin, Franck
    Baudrin, Laurence
    Milleron, Bernard
    Zalcman, Gerard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (01) : 240 - 249
  • [47] Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Saif, Muhammad Wasif
    Syrigos, Kostas
    Penney, Robin
    Kaley, Kristin
    [J]. ANTICANCER RESEARCH, 2010, 30 (07) : 2905 - 2909
  • [48] SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Cullen, M.
    [J]. LUNG CANCER, 2009, 64 : S13 - S13
  • [49] Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer
    Tsang, Erica S.
    Wong, Hui-Li
    Wang, Ying
    Renouf, Daniel John
    Cheung, Winson Y.
    Lim, Howard John
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [50] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Altwegg, Romain
    Ychou, Marc
    Guillaumon, Vanessa
    Thezenas, Simon
    Senesse, Pierre
    Flori, Nicolas
    Mazard, Thibault
    Caillo, Ludovic
    Faure, Stephanie
    Samalin, Emmanuelle
    Assenat, Eric
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (12) : 1357 - 1364
12345